Cargando…
Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data
The generic reference price system (RPS) can impose a financial penalty for patients using a brand name drug instead of its generic alternative. Previous studies on the impact of the RPS have not considered the potentially differential effect of using generic alternatives for individuals with a diff...
Autores principales: | Farfan-Portet, Maria-Isabel, Van de Voorde, Carine, Vrijens, France, Vander Stichele, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343229/ https://www.ncbi.nlm.nih.gov/pubmed/22427042 http://dx.doi.org/10.1007/s10198-012-0377-8 |
Ejemplares similares
-
Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data
por: Vrijens, France, et al.
Publicado: (2011) -
Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023) -
Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019) -
Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)